You are here
,

Novartis buys dry eye drug from Takeda for up to $5.3 billion

  • Friday, 10 May 2019
  • Posted by Aftab Ahmad
  • 0 Comments
Novartis is buying dry-eye drug Xiidra from Takeda Pharmaceutical Co for up to $5.3 billion as the Swiss drugmaker refreshes its ophthalmic medicines portfolio with a potential blockbuster.


from Reuters: Health News https://reut.rs/2VbQday

Aftab Ahmad

We are.., This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

No comments:

Leave a Reply